Merus N.V. EV - Enterprise Value 2011-2026 | MRUS

Annual EV - Enterprise Value Merus N.V.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
2.82 B	2.4 B	831 M	850 M	805 B	344 M	254 M	541 M	368 M	7.86 M	8.63 M	6.58 M	3.32 M	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
805 B	3.32 M	62.6 B

EV - Enterprise Value of other stocks in the Biotechnology industry

Issuer	EV - Enterprise Value	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	1.82 B	-	2.43 %	$ 254 M	Germany
AgeX Therapeutics AGE	3.93 M	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	8.28 B	-	-	$ 866 M	China
Akero Therapeutics AKRO	2.99 B	-	-	$ 3.67 B	USA
Midatech Pharma plc MTP	-1.76 M	-	-18.52 %	$ 27.3 M	Britain
AlloVir ALVR	-55.1 M	-	4.14 %	$ 49.1 M	USA
Alexion Pharmaceuticals, Inc. ALXN	1.95 B	-	-	$ 40.3 B	USA
Aptorum Group Limited APM	9.45 M	$ 0.88	-1.69 %	$ 6.47 M	China
Biophytis SA BPTS	525 M	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	168 B	-	2.54 %	$ 160 B	France
Aquestive Therapeutics AQST	540 M	$ 4.1	1.23 %	$ 438 M	USA
ACADIA Pharmaceuticals ACAD	3.33 B	$ 22.45	1.13 %	$ 3.72 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	3.41 B	-	-1.52 %	$ 24.7 M	USA
Athira Pharma ATHA	-4.92 M	-	-	$ 269 M	USA
Applied Molecular Transport AMTI	7.6 M	-	-	$ 10.1 M	USA
Ayala Pharmaceuticals AYLA	5.32 M	-	-	$ 7.46 M	Israel
AstraZeneca PLC AZN	59.6 B	-	-	$ 96.9 B	Britain
Atreca BCEL	94.8 M	-	-11.76 %	$ 5.79 M	USA
Berkeley Lights BLI	115 M	-	-7.31 %	$ 87 M	USA
Calithera Biosciences CALA	916 M	-	-10.95 %	$ 876 K	USA
Advaxis ADXS	-3.02 M	-	-9.65 %	$ 45.9 M	USA
CymaBay Therapeutics CBAY	3.36 B	-	-	$ 3.45 B	USA
ChemoCentryx CCXI	91.4 M	-	-	$ 3.74 B	USA
Cerus Corporation CERS	632 M	$ 2.03	5.73 %	$ 387 M	USA
Институт стволовых клеток человека ISKJ	14.1 M	-	-	-	Russia
Caladrius Biosciences CLBS	-6.94 M	-	-16.75 %	$ 25.8 M	USA
Checkmate Pharmaceuticals CMPI	11.4 M	-	-	$ 231 M	USA
Kazia Therapeutics Limited KZIA	141 M	$ 13.64	9.82 %	$ 1.81 B	Australia
Aeterna Zentaris AEZS	10.3 M	-	5.93 %	$ 314 M	Canada
BioNTech SE BNTX	-4.91 B	$ 103.45	1.85 %	$ 27.2 B	Germany
Brainstorm Cell Therapeutics BCLI	11 M	-	-2.5 %	$ 5.88 M	USA
Aeglea BioTherapeutics AGLE	-23.2 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	-9.16 M	-	-	$ 26.5 M	USA
Deciphera Pharmaceuticals DCPH	1.24 B	-	-	$ 2.18 B	USA
AIkido Pharma AIKI	9.53 M	-	1.93 %	$ 17.4 M	USA
Innate Pharma S.A. IPHA	259 M	$ 1.44	-3.36 %	$ 235 M	France
Dynavax Technologies Corporation DVAX	2.02 B	-	-	$ 2.02 B	USA
Akouos AKUS	95.1 M	-	0.23 %	$ 488 M	USA
Allakos ALLK	122 M	-	-	$ 28.6 M	USA
Editas Medicine EDIT	218 M	$ 3.0	6.38 %	$ 266 M	USA
Edesa Biotech EDSA	6.91 M	$ 18.27	14.94 %	$ 58.4 M	USA
Can-Fite BioPharma Ltd. CANF	647 M	$ 3.19	6.69 %	$ 5.25 M	Israel
Eiger BioPharmaceuticals EIGR	31 M	-	-9.21 %	$ 2.55 M	USA
Eloxx Pharmaceuticals ELOX	18.7 M	-	-5.68 %	$ 8.28 M	USA
CureVac N.V. CVAC	3.19 B	-	-	$ 867 M	Germany
Ampio Pharmaceuticals AMPE	-1.05 M	-	-11.43 %	$ 502 K	USA
Applied Therapeutics APLT	563 M	-	-	$ 8.42 M	USA
Aptose Biosciences APTO	36.2 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	-18.3 M	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	58.2 M	-	-13.39 %	$ 1.45 M	USA